Patent · US Active

6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof

US9108971B2 · kind B2 · utility

0Cited by

2References

22Claims

0Family size

Assignee

Sanofi · FR

Inventors

Frederic Puech · Rueil-Malmaison, FR
Yulin Chiang · Clay, US
Sylvain COTE DES COMBES · Mennecy, FR
Adrien Tak Li · Fontenay-aux-Roses, FR
Philippe Burnier · Maisons-Laffitte, FR

Key dates

Filing date	May 6, 2013
Grant date	Aug 18, 2015
Priority date	—
Expiry date	May 6, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the 6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]pyridazine derivatives corresponding to general formula (I):Wherein R2, R7, R8, A, L and B are as defined herein. Also disclosed are the preparative methods and therapeutic use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.